Payer MBA positions
The COVID-19 pandemic was an accelerator of shifting consumer preferences and care-delivery innovation. See how, by embracing a digital mindset, health systems can transform their relationship with consumers.
Walmart and UnitedHealth Group are rolling out a major partnership to provide healthcare services and “improve the patient experience” for Medicare Advantage enrollees in certain markets across the country.
India’s drug regulator authorized the country’s first nasal spray vaccine on Tuesday, marking a big step toward increasing the availability of newly popular needle-free vaccines around the world.
Throughout the pandemic, the federal government has provided Americans with Covid-19 tests, vaccines, and treatments free of charge, but this will soon change.
Artificial intelligence models are being used to make labor and pregnancy deliveries safer for mothers and newborns, as A.I. continues to reshape the health care world.
Messages on the popular social media site balked at the retail pharmacy refusing to fill a prescription for non-abortion related care, using #BoycottCVS. At the time of publishing, the tweet had 150,000 likes and 49,000 retweets.
Humana has finished its rebranding of the home health division CenterWell from Kindred at Home, which the insurer acquired in August of last year.
Amazon Web Services tapped 10 startups as finalists to participate in its 2022 healthcare accelerator focused on health equity, it announced Wednesday.
Due to drug overdoses and COVID-19 deaths, life expectancy in the U.S. has dropped for the second straight year.
The Fierce MedTech Summit is the only event where medical device marketers will gather alongside product development, engineering and R&D professionals to share the leading-edge tools and strategies that will propel increased effectiveness in their roles.
A financial services professional has pleaded guilty to insider trading of shares in a clinical stage biotech.
Editas Medicine has confirmed that a cell therapy for sickle cell disease has successfully engrafted into the first patient dosed in a phase 1/2 trial, which means—for those of us without a science degree—the therapy has been accepted by the patient’s body and is starting to create new blood cells as planned.
The US Food and Drug Administration is relaxing its unique device identified (UDI) rule requirements for low-risk class I consumer health products. Other class I and unclassified devices will still need to follow UDI requirements, though FDA announced it will extend its compliance deadline for those devices to 8 December 2022.
The bill to allow Medicare to negotiate some drug prices, cap out-of-pocket drug costs for seniors, and extend temporary subsidies for Affordable Care Act insurance premiums would represent a major step if Democrats can get it across the finish line.
This website uses cookies and similar technologies to understand visitor experiences. By using this website, you consent to UNC-Chapel Hill's cookie usage in accordance with their Privacy Notice.
